Alzheimer's Disease Research Center

$4,437,230P30FY2025AGNIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Paper 39713873 Paper 39711228 Paper 39689057 Paper 39677464 Paper 39649607 Paper 39606367 Paper 39605615 Paper 39578645 Paper 39559880 Paper 39557914 Paper 39554187 Paper 39554163 Paper 39503843 Paper 39496718 Paper 39496102 Paper 39484251 Paper 39483923 Paper 39483910 Paper 39444005 Paper 39437659 Paper 39428957 Paper 39417134 Paper 39412405 Paper 39403075 Paper 39385241 Paper 39379761 Paper 39371140 Paper 39365322 Paper 39352226 Paper 39351959 Paper 39314357 Paper 39308031 Paper 39294787 Paper 39279994 Paper 39276722 Paper 39254167 Paper 39231932 Paper 39195563 Paper 39185475 Paper 39177169 Paper 39165480 Paper 39149376 Paper 39148846 Paper 39137265 Paper 39108475 Paper 39077866 Paper 39055313 Paper 39054278 Paper 39041391 Paper 39020361 Paper 39011113 Paper 39006421 Paper 38997326 Paper 38974877 Paper 38970402 Paper 38965435 Paper 38963256 Paper 38958563 Paper 38958543 Paper 38958117 Paper 38956096 Paper 38947090 Paper 38947004 Paper 38943387 Paper 38940611 Paper 38923730 Paper 38903124 Paper 38896163 Paper 38888066 Paper 38883718 Paper 38880341 Paper 38859733 Paper 38854050 Paper 38853877 Paper 38823362 Paper 38809917 Paper 38803218 Paper 38798451 Paper 38788065 Paper 38780681 Paper 38776513 Paper 38759012 Paper 38755756 Paper 38753380 Paper 38746455 Paper 38746437 Paper 38712073 Paper 38687811 Paper 38683905 Paper 38666355 Paper 38641585 Paper 38623384 Paper 38612729 Paper 38604762 Paper 38602816 Paper 38598986 Paper 38574399 Paper 38559166 Paper 38559129 Paper 38526701

Abstract

Overall: Project Summary â 2P30AG066444-06 The Washington University Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC) initiates, fosters, and supports the performance of innovative, cutting-edge research on Alzheimer disease (AD) and related dementias (ADRD) with regard to the etiology, pathogenesis, diagnosis, treatment, and prevention of disease. We provide well-characterized research participants (persons with symptomatic AD and age-matched controls), their clinical, cognitive, and imaging data, and their biospecimens (DNA, CSF, plasma, dermal fibroblasts, iPSCs, brain tissue) to research projects. We also provide intellectual and financial support to scientists at Washington University, other Alzheimer Disease Research Centers, and the research community nationally and internationally and engage in formal and informal collaborations, including multidisciplinary/multi-Center studies and the initiatives sponsored by the National Institute on Aging and the National Alzheimer Coordinating Center. Historically, our Center has focused on the earliest stages of dementia to identify the initial clinical and pathologic changes that distinguish AD from normal aging. Our approach is balanced between clinical and basic science domains with emphasis on interdisciplinary efforts. We will continue our training of students, fellows, and junior faculty in clinical and basic science research skills. We will continue to engage in outreach activities to transfer information on ADRD to lay and professional audiences. We are committed to assuring that our research cohort includes individuals at higher risk for dementia from the greater metropolitan St. Louis area. This renewal application includes eight Cores, plus the Research Education Component (REC): A: Administrative, B: Clinical, C: Data Management & Statistics, D: Neuropathology, E: Outreach, Recruitment, & Engagement, F: Biomarker, G: Genetics & High Throughput -Omics, and H: Health Disparities Engagement.

View original record on NIH RePORTER →